D-0224-2021 Class III Terminated

Recalled by KVK-Tech, Inc. — Newtown, PA

FDA drug recall D-0224-2021 was initiated by KVK-Tech, Inc. on Dec 18, 2020 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications; out of specification results obtained for N-Oxide impurity during the 12-month long term stability testing for Batch# 15892A The recall status is terminated (terminated Mar 19, 2021). Affected quantity: 528 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 20, 2021
Initiation Date
Dec 18, 2020
Termination Date
Mar 19, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
528 bottles

Product description

Benzhydrocodone and Acetaminophen Tablets, CII, 6.12mg/ 325mg, 100 Tablets, Rx Only, Manufactured for: KVK-Tech, Inc., Newtown, PA 18940 USA, NDC 10702-344-01

Reason for recall

Failed Impurities/Degradation Specifications; out of specification results obtained for N-Oxide impurity during the 12-month long term stability testing for Batch# 15892A

Distribution pattern

Nationwide

Code information

Batch# 15892A, Exp, 2021-FEB

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0224-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0224-2021. Report a data issue: hello@regdatalab.com.